Article

Specialty-lens maker to buy Ocular Sciences

Lake Forest, CA-Cooper Companies, the world's fourth-largest contact lens manufacturer, has set its sights on moving up a notch with the $1.2 billion purchase of Ocular Sciences, who now occupies fifth place.

Lake Forest, CA-Cooper Companies, the world's fourth-largest contact lens manufacturer, has set its sights on moving up a notch with the $1.2 billion purchase of Ocular Sciences, who now occupies fifth place.

Under the deal, specialty lens maker Cooper will get Ocular Sciences in a merger for stock and cash equal to $44 per share of Ocular Sciences' common stock. Cooper, which expects to post revenues in fiscal 2004 of $385 million, will pay $600 million in cash and 10.3 million new Cooper shares. Ocular Sciences projected $342.4 million in revenue for 2004.

Together, the new company expects operational synergies generating $40 million to $50 million in annual pre-tax profits and combined revenues of $930 million to $943 million in 2005.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.